rs139640224

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_017890.5(VPS13B):​c.5980A>G​(p.Ile1994Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00246 in 1,611,550 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 6 hom. )

Consequence

VPS13B
NM_017890.5 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.958

Publications

11 publications found
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
VPS13B Gene-Disease associations (from GenCC):
  • Cohen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008631527).
BP6
Variant 8-99642495-A-G is Benign according to our data. Variant chr8-99642495-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95858.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS13BNM_017890.5 linkc.5980A>G p.Ile1994Val missense_variant Exon 34 of 62 ENST00000358544.7 NP_060360.3 Q7Z7G8-1
VPS13BNM_152564.5 linkc.5905A>G p.Ile1969Val missense_variant Exon 34 of 62 ENST00000357162.7 NP_689777.3 Q7Z7G8-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS13BENST00000358544.7 linkc.5980A>G p.Ile1994Val missense_variant Exon 34 of 62 1 NM_017890.5 ENSP00000351346.2 Q7Z7G8-1
VPS13BENST00000357162.7 linkc.5905A>G p.Ile1969Val missense_variant Exon 34 of 62 1 NM_152564.5 ENSP00000349685.2 Q7Z7G8-2

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
237
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00290
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00154
AC:
379
AN:
246210
AF XY:
0.00142
show subpopulations
Gnomad AFR exome
AF:
0.000320
Gnomad AMR exome
AF:
0.000703
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000166
Gnomad FIN exome
AF:
0.00131
Gnomad NFE exome
AF:
0.00270
Gnomad OTH exome
AF:
0.00100
GnomAD4 exome
AF:
0.00256
AC:
3735
AN:
1459214
Hom.:
6
Cov.:
30
AF XY:
0.00255
AC XY:
1848
AN XY:
725932
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33458
American (AMR)
AF:
0.000719
AC:
32
AN:
44502
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39658
South Asian (SAS)
AF:
0.000534
AC:
46
AN:
86160
European-Finnish (FIN)
AF:
0.00146
AC:
76
AN:
52034
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5734
European-Non Finnish (NFE)
AF:
0.00306
AC:
3405
AN:
1111222
Other (OTH)
AF:
0.00259
AC:
156
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
174
349
523
698
872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00156
AC:
237
AN:
152336
Hom.:
0
Cov.:
32
AF XY:
0.00138
AC XY:
103
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41576
American (AMR)
AF:
0.000523
AC:
8
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00290
AC:
197
AN:
68028
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00230
Hom.:
2
Bravo
AF:
0.00156
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00174
AC:
211
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cohen syndrome Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

May 18, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Sep 28, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VPS13B: BP4 -

Feb 22, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16648375) -

Inborn genetic diseases Benign:1
May 28, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

VPS13B-related disorder Benign:1
Jul 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neutropenia, severe congenital, 1, autosomal dominant Benign:1
Jun 03, 2020
Genetics and Molecular Pathology, SA Pathology
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
13
DANN
Benign
0.66
DEOGEN2
Benign
0.058
.;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.38
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.81
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0086
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;N
PhyloP100
0.96
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.070
N;N
REVEL
Benign
0.058
Sift
Benign
0.78
T;T
Sift4G
Benign
0.24
T;T
Polyphen
0.0
B;B
Vest4
0.15
MVP
0.34
MPC
0.10
ClinPred
0.0010
T
GERP RS
3.5
Varity_R
0.025
gMVP
0.20
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139640224; hg19: chr8-100654723; API